Abstract: The present invention provides a computer-implemented method, computer system and computer program product for data compression. According to the computer-implemented method, one or more data blocks on a data source to be replicated to a data target may be detected. Then, compression performance of a first compression dictionary may be evaluated. The first compression dictionary may be previously used to compress existing data on the data target. If the compression performance is lower than a preset performance threshold, a second compression dictionary may be generated based on the existing data on the data target. The data target may be updated based on the existing data and the one or more data blocks using the second compression dictionary.

Abstract: A semiconductor device includes a first wafer and a second wafer. The semiconductor device includes a seal ring structure comprising a first metal structure in a body of the first wafer, a second metal structure in the body of the first wafer, a third metal structure in a body of the second wafer, and a metal bonding structure including a first set of metal elements coupling the first metal structure and the third metal structure through an interface between the first wafer and the second wafer, and a second set of metal elements coupling the second metal structure and the third metal structure through the interface between the first wafer and the second wafer.

Abstract: A font switching method and an electronic device are provided. A target font consistent with a font currently used by an operating system is found through pixel matching of a dot matrix, and the target font is applied to a third-party application, so that the third-party application can accurately vary with a font change of the operating system. This avoids a problem that the font used by the third-party application software is inconsistent with the font used by the operating system.

Abstract: A method for laser processing a packaging box is provided, which includes feeding a paper material printed with a pattern on the front side thereof to a cutting machine by back feeding using an automatic paper feeder; performing edge finding on the rear side of the paper material, and forming indentations on the rear side of the paper material corresponding to where the pattern is on the front side; conveying the paper material to a laser cutting machine to perform registration marking on the rear side of the paper material before laser cutting; and finally performing laser cutting based on the registration markings to obtain a packaging box with the pattern printed on the front side and the indentations formed on the rear side.

Abstract: A device comprises a plurality of nanosheets, source/drain stressors, and a gate structure wrapping around the nanosheets. The nanosheets extend in a first direction above a semiconductor substrate and are arranged in a second direction substantially perpendicular to the first direction. The source/drain stressors are on either side of the nanosheets. Each of the source/drain stressors comprises a first epitaxial layer and a second epitaxial layer over the first epitaxial layer. The first and second epitaxial layers are made of a Group IV element and a Group V element. An atomic ratio of the Group V element to the Group IV element in the second epitaxial layer is greater than an atomic ratio of the Group V element to the Group IV element in the first epitaxial layer.

Abstract: A semiconductor structure includes an isolation feature formed in the semiconductor substrate and a first fin-type active region. The first fin-type active region extends in a first direction. A dummy gate stack is disposed on an end region of the first fin-type active region. The dummy, gate stack may overlie an isolation structure. In an embodiment, any recess such as formed for a source/drain region in the first fin-type active region will be displaced from the isolation region by the distance the dummy gate stack overlaps the first fin-type active region.

Abstract: A semiconductor device includes a first wafer and a second wafer. The semiconductor device includes a seal ring structure comprising a first metal structure in a body of the first wafer, a second metal structure in the body of the first wafer, a third metal structure in a body of the second wafer, and a metal bonding structure including a first set of metal elements coupling the first metal structure and the third metal structure through an interface between the first wafer and the second wafer, and a second set of metal elements coupling the second metal structure and the third metal structure through the interface between the first wafer and the second wafer.

Abstract: The present disclosure, in some embodiments, relates to a workpiece bonding apparatus. The workpieces bonding apparatus includes a first substrate holder having a first surface configured to receive a first workpiece, and a second substrate holder having a second surface configured to receive a second workpiece. A vacuum apparatus is positioned between the first substrate holder and the second substrate holder and is configured to selectively induce a vacuum between the first surface and the second surface. The vacuum is configured to attract the first surface and the second surface toward one another.

Abstract: The disclosure is directed to, in part, to heterocycle CDK inhibitors, pharmaceutical compositions comprising the same, as well as methods of their use and preparation.

Abstract: A semiconductor structure includes an isolation feature formed in the semiconductor substrate and a first fin-type active region. The first fin-type active region extends in a first direction. A dummy gate stack is disposed on an end region of the first fin-type active region. The dummy gate stack may overlie an isolation structure. In an embodiment, any recess such as formed for a source/drain region in the first fin-type active region will be displaced from the isolation region by the distance the dummy gate stack overlaps the first fin-type active region.

Abstract: The disclosure is directed to, in part, to CDK inhibitors, pharmaceutical compositions comprising the same, as well as methods of their use and preparation.

Abstract: Disclosed are compounds of Formula (I?), methods of using the compounds as immunomodulators, and pharmaceutical compositions comprising such compounds. The compounds inhibit PD-1/PD-L1 interaction and are useful in treating, preventing or ameliorating diseases or disorders such as cancer or infections.

Abstract: The present disclosure provides bifunctional compounds comprising a target protein binding moiety and a E3 ubiquitin ligase binding moiety, and associated methods of use.

Abstract: A self-drilling expanding anchor bolt, including a drill bit for drilling, an anchor rod connected to the drill bit, and an expanding sleeve surrounding the anchor rod, the anchor rod having an expansion cone at a first end adjoining the drill bit, having a neck region behind and contiguous with the expansion cone, and having a threaded segment at a second end of the neck region remote from the drill bit, wherein the expansion cone expands the expanding sleeve in a radial direction when the expansion cone is pulled into the expanding sleeve; a transition part is provided between the drill bit and the expansion cone of the anchor rod, the maximum diameter of the transition part being smaller than the hole diameter of a drilled hole formed by the drill bit.

Abstract: A setting device for a self-drilling anchor bolt of the present invention includes: a drive shaft, one end thereof having a shank for connecting to an impact tool, and another end being a setting part for pushing the self-drilling anchor bolt axially; a coupling, partially surrounding the drive shaft along an axis, and being supported on the drive shaft in such a way as to be incapable of relative rotation while being axially moveable at least locally; and a releasable locking component, disposed between the drive shaft and the coupling; in a locked position, the locking component is coupled to an extremity of an anchor rod such that the anchor rod is fed axially with rotational striking into a receiving material, and in a released position, the drive shaft strikes a sleeve to advance axially along the anchor rod and expand at an expansion part.

Abstract: The present disclosure relates to a class of JAK inhibitor compounds for treating severe pneumonia. Specifically, the present disclosure discloses a method for treating severe pneumonia, the method comprising administering to a patient in need thereof a therapeutically effective amount of a compound represented by formula (G), isotopically labeled compound thereof, or optical isomer thereof, geometric isomer thereof, a tautomer thereof or a mixture of various isomers, or a pharmaceutically acceptable salt thereof, or a prodrug thereof, or a metabolite thereof.

Abstract: The present disclosure relates to a class of JAK inhibitor compounds and uses thereof. Specifically, the present disclosure discloses a compound represented by formula (G), isotopically labeled compound thereof, or optical isomer thereof, geometric isomer thereof, a tautomer thereof or a mixture of various isomers, or a pharmaceutically acceptable salt thereof, or a prodrug thereof, or a metabolite thereof. The present disclosure also relates to the application of the compounds in medicine.

Abstract: The present disclosure relates to FGFR inhibitor compounds and its use. Specifically, the present disclosure discloses a compound represented by formula (I), isotopically labeled compound thereof, or optical isomer thereof, geometric isomer thereof, a tautomer thereof or a mixture of various isomers, or a pharmaceutically acceptable salt thereof, or a prodrug thereof, or a metabolite thereof. The present disclosure also relates to use of the above compound in medicine.

Abstract: The present disclosure relates to a JAK inhibitor compound and uses thereof. Specifically, the present disclosure discloses a compound of formula (G) in a solid form, isotopically labeled compound thereof, or optical isomer thereof, geometric isomer thereof, a tautomer thereof or a mixture of various isomers, or a pharmaceutically acceptable salt thereof, or a prodrug thereof, or a metabolite thereof. The present disclosure also relates to the application of the compound in a solid form in medicine.

Abstract: Disclosed are compounds of Formula (I), methods of using the compounds as immunomodulators, and pharmaceutical compositions comprising such compounds. The compounds are useful in treating, preventing or ameliorating diseases or disorders such as cancer or infections.